

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte aggregation (GO:0070486) | 7.21853893 |
| 2 | response to peptidoglycan (GO:0032494) | 7.14004108 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.90117621 |
| 4 | respiratory burst (GO:0045730) | 6.41171953 |
| 5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 5.89829757 |
| 6 | hydrogen peroxide biosynthetic process (GO:0050665) | 5.86268053 |
| 7 | cellular extravasation (GO:0045123) | 5.73611643 |
| 8 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.54241699 |
| 9 | neutrophil activation (GO:0042119) | 5.54051441 |
| 10 | reactive oxygen species biosynthetic process (GO:1903409) | 5.43704306 |
| 11 | superoxide anion generation (GO:0042554) | 5.37935706 |
| 12 | granulocyte activation (GO:0036230) | 5.32746044 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.24261284 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.24261284 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 5.24261284 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 5.24261284 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 5.24261284 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.24261284 |
| 19 | neutrophil mediated immunity (GO:0002446) | 4.91863738 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 4.84453943 |
| 21 | positive regulation of mast cell degranulation (GO:0043306) | 4.81770652 |
| 22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.81770652 |
| 23 | defense response to fungus (GO:0050832) | 4.77134592 |
| 24 | response to fungus (GO:0009620) | 4.76766233 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.61735372 |
| 26 | response to host immune response (GO:0052572) | 4.60422528 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.60422528 |
| 28 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.58175673 |
| 29 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.58175673 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 4.41942133 |
| 31 | neutrophil chemotaxis (GO:0030593) | 4.37148643 |
| 32 | sequestering of metal ion (GO:0051238) | 4.32844366 |
| 33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.26864214 |
| 34 | neutrophil migration (GO:1990266) | 4.25370379 |
| 35 | regulation of mast cell activation (GO:0033003) | 4.19524938 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.16393293 |
| 37 | response to host (GO:0075136) | 4.16393293 |
| 38 | response to host defenses (GO:0052200) | 4.16393293 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.14696637 |
| 40 | regulation of leukocyte degranulation (GO:0043300) | 4.14383731 |
| 41 | detection of other organism (GO:0098543) | 4.13013951 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 4.06463524 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.96927161 |
| 44 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.96233065 |
| 45 | myeloid leukocyte mediated immunity (GO:0002444) | 3.93603556 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92774425 |
| 47 | negative regulation of cell killing (GO:0031342) | 3.92774425 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.88777566 |
| 49 | detection of bacterium (GO:0016045) | 3.83807048 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.82448783 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 3.82148304 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.79294031 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.78129577 |
| 54 | granulocyte chemotaxis (GO:0071621) | 3.77841266 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.76687528 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.75199924 |
| 57 | granulocyte migration (GO:0097530) | 3.73202749 |
| 58 | positive regulation of leukocyte degranulation (GO:0043302) | 3.72784655 |
| 59 | phagosome maturation (GO:0090382) | 3.72603269 |
| 60 | leukotriene metabolic process (GO:0006691) | 3.72578168 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.72547037 |
| 62 | microglial cell activation (GO:0001774) | 3.66224029 |
| 63 | leukocyte mediated cytotoxicity (GO:0001909) | 3.65222807 |
| 64 | leukocyte cell-cell adhesion (GO:0007159) | 3.65150236 |
| 65 | lipoxygenase pathway (GO:0019372) | 3.64394665 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.59480095 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.58733361 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58490033 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.55697781 |
| 70 | regulation of regulated secretory pathway (GO:1903305) | 3.54986773 |
| 71 | mast cell activation (GO:0045576) | 3.54952032 |
| 72 | chronic inflammatory response (GO:0002544) | 3.53097029 |
| 73 | B cell mediated immunity (GO:0019724) | 3.49087240 |
| 74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.43618518 |
| 75 | regulation of gamma-delta T cell activation (GO:0046643) | 3.40518902 |
| 76 | killing of cells of other organism (GO:0031640) | 3.36395016 |
| 77 | disruption of cells of other organism (GO:0044364) | 3.36395016 |
| 78 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.36125271 |
| 79 | negative regulation of growth of symbiont in host (GO:0044130) | 3.34739611 |
| 80 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.34739611 |
| 81 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.34739611 |
| 82 | regulation of growth of symbiont in host (GO:0044126) | 3.34739611 |
| 83 | detection of external biotic stimulus (GO:0098581) | 3.30838005 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27016453 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 3.25929042 |
| 86 | T-helper 1 type immune response (GO:0042088) | 3.25480110 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25152807 |
| 88 | detection of molecule of bacterial origin (GO:0032490) | 3.20208519 |
| 89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.20180652 |
| 90 | myeloid leukocyte activation (GO:0002274) | 3.16874471 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16614849 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16614849 |
| 93 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.13745065 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.13368261 |
| 95 | germinal center formation (GO:0002467) | 3.09696442 |
| 96 | leukocyte degranulation (GO:0043299) | 3.08167836 |
| 97 | macrophage differentiation (GO:0030225) | 3.07951870 |
| 98 | regulation of interferon-alpha production (GO:0032647) | 3.04492441 |
| 99 | cellular response to zinc ion (GO:0071294) | 3.01164251 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.99890865 |
| 101 | negative regulation of interleukin-6 production (GO:0032715) | 2.99129724 |
| 102 | defense response to protozoan (GO:0042832) | 2.98271637 |
| 103 | leukotriene biosynthetic process (GO:0019370) | 2.97197770 |
| 104 | cell killing (GO:0001906) | 2.95907324 |
| 105 | regulation of chemokine biosynthetic process (GO:0045073) | 2.95606392 |
| 106 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94692408 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94686569 |
| 108 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93233256 |
| 109 | defense response to Gram-positive bacterium (GO:0050830) | 2.92914053 |
| 110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.92727394 |
| 111 | positive regulation of B cell differentiation (GO:0045579) | 2.92068222 |
| 112 | myeloid leukocyte migration (GO:0097529) | 2.89805227 |
| 113 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89574140 |
| 114 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.89098621 |
| 115 | negative regulation of mast cell activation (GO:0033004) | 2.87848973 |
| 116 | positive regulation of regulated secretory pathway (GO:1903307) | 2.87139338 |
| 117 | regulation of hypersensitivity (GO:0002883) | 2.86606770 |
| 118 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.85360409 |
| 119 | macrophage activation (GO:0042116) | 2.85316562 |
| 120 | detection of biotic stimulus (GO:0009595) | 2.85100253 |
| 121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.84878039 |
| 122 | negative regulation of innate immune response (GO:0045824) | 2.83109968 |
| 123 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.82616890 |
| 124 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79547704 |
| 125 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.77489916 |
| 126 | regulation of platelet aggregation (GO:0090330) | 2.77432420 |
| 127 | B cell receptor signaling pathway (GO:0050853) | 2.77171454 |
| 128 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.74702164 |
| 129 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.72961723 |
| 130 | cytokine secretion (GO:0050663) | 2.72749219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.53121594 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.42372122 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89878973 |
| 4 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.32589960 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.23585693 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.13835738 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.03400512 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.89069591 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71214025 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.63801979 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.23939678 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00665088 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96072570 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.95806466 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.89863640 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.81868165 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61694275 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61105013 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60763331 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59092050 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34257539 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27323282 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.22196789 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08338091 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07670698 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.98230794 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98074270 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 1.93777395 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91213170 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89742693 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.88038672 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85639483 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83623494 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.82876787 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.79759905 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76926538 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76051732 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.74393754 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.72926065 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66786264 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65104326 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64728478 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64181067 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59547089 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52351115 |
| 46 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51700856 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.50875733 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50154107 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.46450678 |
| 50 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43796622 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41987008 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39646423 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.35172943 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34719049 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31303078 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31236618 |
| 57 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30288022 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29696834 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26508954 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25696914 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23565820 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21102463 |
| 63 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20179986 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18632490 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16291317 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15196756 |
| 67 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12026160 |
| 68 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10471804 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10141281 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08465692 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06996647 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05399739 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04930123 |
| 74 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02145422 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01265309 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00704963 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99440524 |
| 78 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.98404768 |
| 79 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97692118 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96938817 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 0.96247675 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95109879 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94419790 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93115540 |
| 85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91559070 |
| 86 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90584958 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90452110 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89920237 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88615295 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88190932 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87797062 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85984448 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84052259 |
| 94 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83986850 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 0.83427645 |
| 96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82062719 |
| 97 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79770070 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78796768 |
| 99 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77801449 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76885834 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75212095 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74112989 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71756266 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.68176887 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.67796019 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67271930 |
| 107 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.66824296 |
| 108 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66129114 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.65828050 |
| 110 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.65464429 |
| 111 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.65355110 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.65098313 |
| 113 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.61106630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 5.02486210 |
| 2 | MP0003303_peritoneal_inflammation | 4.38542295 |
| 3 | MP0009785_altered_susceptibility_to | 4.08819315 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.79507661 |
| 5 | MP0002419_abnormal_innate_immunity | 3.74103917 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.30553936 |
| 7 | MP0003724_increased_susceptibility_to | 3.23634213 |
| 8 | MP0009278_abnormal_bone_marrow | 3.18043477 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.14049980 |
| 10 | MP0005025_abnormal_response_to | 3.13854181 |
| 11 | MP0005387_immune_system_phenotype | 2.68460284 |
| 12 | MP0001790_abnormal_immune_system | 2.68460284 |
| 13 | MP0001533_abnormal_skeleton_physiology | 2.64414477 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.58614497 |
| 15 | MP0000685_abnormal_immune_system | 2.54752958 |
| 16 | MP0004510_myositis | 2.50038683 |
| 17 | MP0001800_abnormal_humoral_immune | 2.38671622 |
| 18 | MP0002723_abnormal_immune_serum | 2.33127770 |
| 19 | MP0001819_abnormal_immune_cell | 2.31753457 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.30891294 |
| 21 | MP0001853_heart_inflammation | 2.18290739 |
| 22 | MP0002405_respiratory_system_inflammati | 2.16843689 |
| 23 | MP0003075_altered_response_to | 2.10087878 |
| 24 | MP0000343_altered_response_to | 2.07391629 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.06009591 |
| 26 | MP0001845_abnormal_inflammatory_respons | 2.04220432 |
| 27 | MP0009764_decreased_sensitivity_to | 2.03345704 |
| 28 | MP0006082_CNS_inflammation | 2.02359858 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.01151346 |
| 30 | MP0003183_abnormal_peptide_metabolism | 2.00001137 |
| 31 | MP0005671_abnormal_response_to | 1.96115125 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.89573117 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.84292925 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.84292925 |
| 35 | MP0004947_skin_inflammation | 1.80429767 |
| 36 | MP0000858_altered_metastatic_potential | 1.78065095 |
| 37 | MP0003448_altered_tumor_morphology | 1.76145123 |
| 38 | MP0008004_abnormal_stomach_pH | 1.74708377 |
| 39 | MP0002006_tumorigenesis | 1.74356021 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.61110796 |
| 41 | MP0000716_abnormal_immune_system | 1.58654539 |
| 42 | MP0008469_abnormal_protein_level | 1.58447882 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.58363591 |
| 44 | MP0003828_pulmonary_edema | 1.51940340 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.51597053 |
| 46 | MP0002277_abnormal_respiratory_mucosa | 1.51488481 |
| 47 | MP0001851_eye_inflammation | 1.46583702 |
| 48 | MP0002398_abnormal_bone_marrow | 1.43964210 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.37199423 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.36625367 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.36243893 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.35202605 |
| 53 | MP0005166_decreased_susceptibility_to | 1.31183852 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.29028657 |
| 55 | MP0005310_abnormal_salivary_gland | 1.28636407 |
| 56 | MP0002429_abnormal_blood_cell | 1.26959141 |
| 57 | MP0005390_skeleton_phenotype | 1.26212049 |
| 58 | MP0002933_joint_inflammation | 1.25825099 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.24103326 |
| 60 | MP0000689_abnormal_spleen_morphology | 1.21474164 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.20101220 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.19692533 |
| 63 | MP0005164_abnormal_response_to | 1.11271546 |
| 64 | MP0002722_abnormal_immune_system | 1.11139541 |
| 65 | MP0008260_abnormal_autophagy | 1.09647922 |
| 66 | MP0004883_abnormal_blood_vessel | 1.07738929 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.07435134 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.02176284 |
| 69 | MP0005083_abnormal_biliary_tract | 0.97104673 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.96142612 |
| 71 | MP0004808_abnormal_hematopoietic_stem | 0.94670390 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.93529790 |
| 73 | MP0003186_abnormal_redox_activity | 0.91738579 |
| 74 | MP0001873_stomach_inflammation | 0.91291387 |
| 75 | MP0009763_increased_sensitivity_to | 0.89318313 |
| 76 | MP0009840_abnormal_foam_cell | 0.85840943 |
| 77 | MP0002132_abnormal_respiratory_system | 0.83083065 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.82382966 |
| 79 | MP0000604_amyloidosis | 0.82054229 |
| 80 | MP0000249_abnormal_blood_vessel | 0.80613866 |
| 81 | MP0001958_emphysema | 0.80442383 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.79729116 |
| 83 | MP0004381_abnormal_hair_follicle | 0.75341766 |
| 84 | MP0005023_abnormal_wound_healing | 0.75299006 |
| 85 | MP0001663_abnormal_digestive_system | 0.74447805 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.71956325 |
| 87 | MP0008874_decreased_physiological_sensi | 0.69221847 |
| 88 | MP0003690_abnormal_glial_cell | 0.69117183 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.68078228 |
| 90 | MP0001542_abnormal_bone_strength | 0.67430180 |
| 91 | MP0002396_abnormal_hematopoietic_system | 0.67049201 |
| 92 | MP0003795_abnormal_bone_structure | 0.65217319 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.64825151 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.62306619 |
| 95 | MP0000490_abnormal_crypts_of | 0.60971041 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.58798888 |
| 97 | MP0000767_abnormal_smooth_muscle | 0.57851229 |
| 98 | MP0003329_amyloid_beta_deposits | 0.57665034 |
| 99 | MP0003091_abnormal_cell_migration | 0.57527483 |
| 100 | MP0002133_abnormal_respiratory_system | 0.56586873 |
| 101 | MP0005388_respiratory_system_phenotype | 0.56586873 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.55835545 |
| 103 | MP0003866_abnormal_defecation | 0.54763898 |
| 104 | MP0010352_gastrointestinal_tract_polyps | 0.54224744 |
| 105 | MP0005451_abnormal_body_composition | 0.52786688 |
| 106 | MP0000920_abnormal_myelination | 0.51918849 |
| 107 | MP0000371_diluted_coat_color | 0.51911828 |
| 108 | MP0004130_abnormal_muscle_cell | 0.51806392 |
| 109 | MP0003045_fibrosis | 0.49302397 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.48976151 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.47331239 |
| 112 | MP0000609_abnormal_liver_physiology | 0.46966493 |
| 113 | MP0003279_aneurysm | 0.46730438 |
| 114 | MP0003763_abnormal_thymus_physiology | 0.45608406 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.45124556 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.44894192 |
| 117 | MP0005084_abnormal_gallbladder_morpholo | 0.44534202 |
| 118 | MP0008873_increased_physiological_sensi | 0.43750665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 9.71344439 |
| 2 | Recurrent abscess formation (HP:0002722) | 9.41293256 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 8.96340591 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 8.40810433 |
| 5 | Abnormality of macrophages (HP:0004311) | 6.13321934 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.92686905 |
| 7 | Chronic obstructive pulmonary disease (HP:0006510) | 5.68070344 |
| 8 | Obstructive lung disease (HP:0006536) | 5.68070344 |
| 9 | Gingivitis (HP:0000230) | 5.54177658 |
| 10 | Recurrent skin infections (HP:0001581) | 4.87574800 |
| 11 | Myositis (HP:0100614) | 4.80973795 |
| 12 | Orchitis (HP:0100796) | 4.65869867 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.56475195 |
| 14 | Stomatitis (HP:0010280) | 4.33719789 |
| 15 | Optic neuritis (HP:0100653) | 4.28557764 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.28557764 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.22402946 |
| 18 | Urticaria (HP:0001025) | 4.11767736 |
| 19 | Cellulitis (HP:0100658) | 4.08112352 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 4.07466472 |
| 21 | Meningitis (HP:0001287) | 3.65694293 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.51679540 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.37792871 |
| 24 | Abnormal platelet volume (HP:0011876) | 3.36097579 |
| 25 | Vasculitis (HP:0002633) | 3.33715619 |
| 26 | Spontaneous hematomas (HP:0007420) | 3.27968248 |
| 27 | Periodontitis (HP:0000704) | 3.25024943 |
| 28 | Episodic fever (HP:0001954) | 3.12828545 |
| 29 | Pustule (HP:0200039) | 3.09268998 |
| 30 | Recurrent viral infections (HP:0004429) | 3.03721537 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 2.96404928 |
| 32 | Recurrent pneumonia (HP:0006532) | 2.96080247 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.92463558 |
| 34 | Peritonitis (HP:0002586) | 2.90379492 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.80523419 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74006028 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74006028 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.73937165 |
| 39 | Increased mean platelet volume (HP:0011877) | 2.72270005 |
| 40 | Osteomyelitis (HP:0002754) | 2.70937074 |
| 41 | Increased serum ferritin (HP:0003281) | 2.70808717 |
| 42 | Leukocytosis (HP:0001974) | 2.67951315 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.67535666 |
| 44 | Hemoptysis (HP:0002105) | 2.65718974 |
| 45 | Loss of speech (HP:0002371) | 2.64428524 |
| 46 | Arterial thrombosis (HP:0004420) | 2.63608917 |
| 47 | Axonal loss (HP:0003447) | 2.59855441 |
| 48 | Glomerulonephritis (HP:0000099) | 2.58379292 |
| 49 | Abnormality of iron homeostasis (HP:0011031) | 2.54832662 |
| 50 | Premature loss of primary teeth (HP:0006323) | 2.54179600 |
| 51 | Increased IgM level (HP:0003496) | 2.50465375 |
| 52 | Recurrent lower respiratory tract infections (HP:0002783) | 2.45884639 |
| 53 | Sepsis (HP:0100806) | 2.43274451 |
| 54 | Abnormal platelet function (HP:0011869) | 2.41628302 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.41628302 |
| 56 | Gingival bleeding (HP:0000225) | 2.37572622 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.30223563 |
| 58 | IgM deficiency (HP:0002850) | 2.29329243 |
| 59 | Increased cerebral lipofuscin (HP:0011813) | 2.26740114 |
| 60 | Pulmonary embolism (HP:0002204) | 2.26051331 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25898045 |
| 62 | Petechiae (HP:0000967) | 2.25051993 |
| 63 | Skin ulcer (HP:0200042) | 2.23240652 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.22317585 |
| 65 | Chest pain (HP:0100749) | 2.20397059 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.19659263 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19093571 |
| 68 | Hematochezia (HP:0002573) | 2.18690226 |
| 69 | Epistaxis (HP:0000421) | 2.17904882 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17412606 |
| 71 | Metaphyseal cupping (HP:0003021) | 2.13017790 |
| 72 | Disinhibition (HP:0000734) | 2.12291902 |
| 73 | Panhypogammaglobulinemia (HP:0003139) | 2.11072613 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11035254 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.11035254 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.07058827 |
| 77 | Hypochromic anemia (HP:0001931) | 2.06931572 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.06909969 |
| 79 | Joint hemorrhage (HP:0005261) | 2.06437827 |
| 80 | Chronic otitis media (HP:0000389) | 2.04961066 |
| 81 | Encephalitis (HP:0002383) | 2.03866912 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.03790979 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.03664401 |
| 84 | Nephritis (HP:0000123) | 2.03354483 |
| 85 | Amyloidosis (HP:0011034) | 2.01829066 |
| 86 | Thick nail (HP:0001805) | 1.99908148 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 1.99226097 |
| 88 | Myocardial infarction (HP:0001658) | 1.98896009 |
| 89 | Colitis (HP:0002583) | 1.95700679 |
| 90 | Eosinophilia (HP:0001880) | 1.95186463 |
| 91 | T lymphocytopenia (HP:0005403) | 1.95017034 |
| 92 | Prostate neoplasm (HP:0100787) | 1.93895587 |
| 93 | Muscle fiber splitting (HP:0003555) | 1.93753356 |
| 94 | Pathologic fracture (HP:0002756) | 1.93202657 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.92652495 |
| 96 | Vertigo (HP:0002321) | 1.91158951 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.90934471 |
| 98 | Abnormality of T cell number (HP:0011839) | 1.90862303 |
| 99 | Gangrene (HP:0100758) | 1.89773107 |
| 100 | Abnormality of T cells (HP:0002843) | 1.88379622 |
| 101 | Progressive neurologic deterioration (HP:0002344) | 1.87151373 |
| 102 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86432363 |
| 103 | Joint swelling (HP:0001386) | 1.86198259 |
| 104 | Malnutrition (HP:0004395) | 1.86007716 |
| 105 | Abnormality of the pericardium (HP:0001697) | 1.85602601 |
| 106 | Increased IgE level (HP:0003212) | 1.83047985 |
| 107 | Anorexia (HP:0002039) | 1.81888535 |
| 108 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.81555497 |
| 109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.81555497 |
| 110 | Abnormality of glycolipid metabolism (HP:0010969) | 1.81555497 |
| 111 | Purpura (HP:0000979) | 1.80954365 |
| 112 | Cheilitis (HP:0100825) | 1.80759650 |
| 113 | Inflammation of the large intestine (HP:0002037) | 1.79139973 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78332037 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.78332037 |
| 116 | Hypermelanotic macule (HP:0001034) | 1.76249555 |
| 117 | Granulocytopenia (HP:0001913) | 1.75246758 |
| 118 | Agnosia (HP:0010524) | 1.75021784 |
| 119 | Abnormality of the nasal mucosa (HP:0000433) | 1.74358788 |
| 120 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.73902989 |
| 121 | Menorrhagia (HP:0000132) | 1.72454589 |
| 122 | Poor head control (HP:0002421) | 1.68711509 |
| 123 | Abnormality of T cell physiology (HP:0011840) | 1.68523234 |
| 124 | Thoracic kyphosis (HP:0002942) | 1.68234553 |
| 125 | Glomerulopathy (HP:0100820) | 1.68072891 |
| 126 | Restrictive lung disease (HP:0002091) | 1.67297860 |
| 127 | Papilledema (HP:0001085) | 1.67070860 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66251585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.34239988 |
| 2 | IRAK4 | 4.46499146 |
| 3 | BLK | 4.18088496 |
| 4 | MAP3K14 | 3.28724592 |
| 5 | MAP4K1 | 3.12972098 |
| 6 | CSK | 2.71072836 |
| 7 | FGR | 2.53297418 |
| 8 | ERN1 | 2.40501994 |
| 9 | TNK2 | 2.33599348 |
| 10 | TBK1 | 2.23271121 |
| 11 | EPHB1 | 2.21568745 |
| 12 | TYK2 | 2.09740128 |
| 13 | IRAK3 | 2.04828616 |
| 14 | TXK | 1.91846959 |
| 15 | STK10 | 1.83953793 |
| 16 | BTK | 1.80398640 |
| 17 | TAOK1 | 1.80334864 |
| 18 | FES | 1.79745873 |
| 19 | MAP3K6 | 1.78027815 |
| 20 | IKBKB | 1.71854346 |
| 21 | PRPF4B | 1.68024091 |
| 22 | CLK1 | 1.64719105 |
| 23 | HCK | 1.62627515 |
| 24 | TESK1 | 1.60657141 |
| 25 | IKBKE | 1.58855747 |
| 26 | MAP2K3 | 1.56371344 |
| 27 | JAK3 | 1.52052242 |
| 28 | MAP3K13 | 1.49826557 |
| 29 | TRPM7 | 1.47915724 |
| 30 | TEC | 1.43456707 |
| 31 | ZAP70 | 1.43436591 |
| 32 | MAP3K12 | 1.37166337 |
| 33 | RIPK1 | 1.35944203 |
| 34 | SIK3 | 1.33216349 |
| 35 | GRK6 | 1.31546635 |
| 36 | MARK3 | 1.31238571 |
| 37 | JAK1 | 1.26785551 |
| 38 | SYK | 1.20232992 |
| 39 | CSF1R | 1.18227586 |
| 40 | MAP3K11 | 1.14857345 |
| 41 | MATK | 1.10194463 |
| 42 | LRRK2 | 1.09625738 |
| 43 | LYN | 1.08942354 |
| 44 | KIT | 1.08671931 |
| 45 | TAOK2 | 1.06312578 |
| 46 | PIM1 | 1.05769719 |
| 47 | BMX | 1.03936354 |
| 48 | KSR2 | 1.03274885 |
| 49 | JAK2 | 1.02530911 |
| 50 | BMPR2 | 1.00565132 |
| 51 | TTN | 0.98075547 |
| 52 | YES1 | 0.93422565 |
| 53 | TESK2 | 0.91263612 |
| 54 | PBK | 0.90514459 |
| 55 | MARK2 | 0.90158276 |
| 56 | TGFBR2 | 0.88267243 |
| 57 | IRAK1 | 0.88222210 |
| 58 | MST1R | 0.87068177 |
| 59 | LCK | 0.86825131 |
| 60 | PTK2B | 0.85850073 |
| 61 | ERBB3 | 0.85044046 |
| 62 | MAP2K4 | 0.84746487 |
| 63 | IRAK2 | 0.82921898 |
| 64 | CAMK1D | 0.80831884 |
| 65 | PRKD2 | 0.79148418 |
| 66 | PRKCD | 0.79032433 |
| 67 | MAPK12 | 0.78915269 |
| 68 | ABL2 | 0.77816934 |
| 69 | CHUK | 0.76713588 |
| 70 | TAOK3 | 0.76092297 |
| 71 | KDR | 0.70030998 |
| 72 | PTK6 | 0.69331682 |
| 73 | TRIB3 | 0.67670410 |
| 74 | STK4 | 0.66370319 |
| 75 | PAK4 | 0.65901632 |
| 76 | RPS6KA6 | 0.63957626 |
| 77 | CDC42BPA | 0.63456503 |
| 78 | MAP2K6 | 0.63381213 |
| 79 | EPHA3 | 0.62505683 |
| 80 | MAP3K3 | 0.61298988 |
| 81 | MAP3K9 | 0.61123959 |
| 82 | RET | 0.60984816 |
| 83 | RPS6KA4 | 0.60593371 |
| 84 | FGFR3 | 0.60045263 |
| 85 | PIM2 | 0.60009657 |
| 86 | RPS6KL1 | 0.58189683 |
| 87 | RPS6KC1 | 0.58189683 |
| 88 | ITK | 0.57810090 |
| 89 | MAP3K1 | 0.57273531 |
| 90 | EGFR | 0.57131607 |
| 91 | MAPKAPK2 | 0.57070597 |
| 92 | SIK2 | 0.56127824 |
| 93 | FYN | 0.55904094 |
| 94 | PRKG2 | 0.55607238 |
| 95 | DAPK2 | 0.54556945 |
| 96 | EIF2AK2 | 0.54259608 |
| 97 | LIMK1 | 0.54229573 |
| 98 | ABL1 | 0.53238798 |
| 99 | PDPK1 | 0.50424084 |
| 100 | MAPK4 | 0.48984622 |
| 101 | MAPK7 | 0.47521809 |
| 102 | DAPK1 | 0.47466138 |
| 103 | PDK1 | 0.43969860 |
| 104 | STK24 | 0.43370387 |
| 105 | PRKD1 | 0.41878075 |
| 106 | CAMK1G | 0.40475149 |
| 107 | MAP3K2 | 0.39417513 |
| 108 | ALK | 0.37898602 |
| 109 | MST4 | 0.36860454 |
| 110 | SGK3 | 0.36653166 |
| 111 | PRKCH | 0.35614381 |
| 112 | PRKCQ | 0.34851290 |
| 113 | GRK7 | 0.34477050 |
| 114 | MAP3K7 | 0.34352033 |
| 115 | STK11 | 0.33452452 |
| 116 | DMPK | 0.33232169 |
| 117 | MAP3K5 | 0.32861339 |
| 118 | SIK1 | 0.32655062 |
| 119 | PIK3CG | 0.32439190 |
| 120 | RAF1 | 0.32226487 |
| 121 | HIPK2 | 0.31981024 |
| 122 | PTK2 | 0.31496848 |
| 123 | RPS6KA2 | 0.30651063 |
| 124 | MOS | 0.30493772 |
| 125 | RPS6KA1 | 0.30079071 |
| 126 | PKN2 | 0.27885618 |
| 127 | PRKCZ | 0.25793327 |
| 128 | CAMKK2 | 0.24410715 |
| 129 | DYRK1B | 0.23421342 |
| 130 | PDGFRB | 0.23315964 |
| 131 | MAP3K8 | 0.22843783 |
| 132 | NEK9 | 0.22797722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.13701911 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 4.12012934 |
| 3 | Legionellosis_Homo sapiens_hsa05134 | 2.83487783 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73702953 |
| 5 | Pertussis_Homo sapiens_hsa05133 | 2.64448809 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.55305315 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37600743 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.37397961 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.25194305 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.20398532 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18919401 |
| 12 | Malaria_Homo sapiens_hsa05144 | 2.07599701 |
| 13 | Salmonella infection_Homo sapiens_hsa05132 | 2.03876378 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.97633459 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91980556 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89380260 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.88471239 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.84222843 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82993323 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.82775037 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74152115 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.69807545 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.65025489 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.64509389 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64302169 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.59093531 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.57912416 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53329442 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52648603 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52384716 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.48484331 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48096343 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.42289391 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40550964 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.37792940 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35033362 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26927863 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.18539108 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16968464 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15544139 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14761158 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.14421525 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11078436 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08546692 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.03906497 |
| 46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01604863 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.00080777 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99371135 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.97685520 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97318283 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97304291 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95968281 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95348779 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91654585 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.90229460 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84709412 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78386640 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.77292104 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72175674 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71736282 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68222133 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67291957 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64010526 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61028659 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60685070 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59280970 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.57313023 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56689601 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56582085 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.56019425 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55637552 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54818231 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54225506 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53844452 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53363025 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51446378 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50969651 |
| 78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50253848 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49054835 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48486622 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47033648 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.44955307 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43469985 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43284025 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42829410 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41671787 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.41591526 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.40210745 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39682440 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39591623 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.38662056 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38625363 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38163116 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36732598 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33114407 |
| 96 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31758444 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28503325 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28043555 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27332725 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26891184 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24164561 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23784218 |
| 103 | Adherens junction_Homo sapiens_hsa04520 | 0.22904743 |
| 104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.21152067 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19997416 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19269164 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.18110389 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17113166 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15989579 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.15700054 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.13979211 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.12578075 |

